Buy Atara Biotherapeutics Stock | ATRA Stock Price & Latest News | Public
ATRA

Atara Biotherapeutics

$0.00 (0.00%)Today

    About ATRA

    Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founde...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.45
    -0.91
    -1.36
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.09

    Actual EPS
    Q3 2020

    Stats

    Market Cap$1,16B
    Volume33,38k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$19.36
    1 Year Low$4.52
    Open$15.36
    High$15.96
    Low$15.31

    Buy any stock with any amount of money.

    Download the App
    Download the app